Efficacy / safety balance of DPP-4 inhibitors versus SGLT2 inhibitors in elderly patients with type 2 diabetes
André Scheen
Topics & Concepts
MedicineSitagliptinType 2 diabetesPopulationAdverse effectDiabetes mellitusIntensive care medicineInternal medicineEndocrinologyEnvironmental healthDiabetes Treatment and ManagementPeptidase Inhibition and AnalysisPotassium and Related Disorders